Dietary Calcium Intake in Premenstrual Syndrome
Effect of Sufficient Dietary Calcium Intake in Women With Premenstrual Syndrome
1 other identifier
interventional
31
1 country
1
Brief Summary
This study was planned and conducted to investigate effect of adequate calcium intake on Premenstrual Syndrome (PMS) symptoms in women with PMS who have inadequate calcium intake.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 16, 2016
CompletedFirst Posted
Study publicly available on registry
June 22, 2016
CompletedJune 22, 2016
June 1, 2016
10 months
June 16, 2016
June 21, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Premenstrual Syndrome Scale (PMSS)
Premenstrual Syndrome Scale (PMSS) was used for symptom assessment at initial and after two menstrual cycles.
Eight weeks
Secondary Outcomes (1)
Change in Quality of life scale Short Form (SF-36)
Eight weeks
Study Arms (2)
Interventional group
EXPERIMENTAL8-week follow- up with dietary sufficient calcium intake
Control group
NO INTERVENTION8-week follow- up with no specific diet
Interventions
Intervention group was ensured to take at least 1000 mg calcium from foods, 700-800 mg of it from dairy and dairy products, according to Recommended Dietary Allowances (RDA), for two months. These foods were; * 50 gr kashkaval cheese, * 400 ml milk and * 150 gr yogurt for each day.
Eligibility Criteria
You may qualify if:
- Women with;
- PMS who have inadequate calcium intake
- Regular menstrual cycle
- Menstrual flow which occurs every 22 to 35 days and last three to eight days
You may not qualify if:
- Having any of metabolic diseases
- Use oral contraceptive pill
- user vitamins and minerals supplements
- being smoker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eastern Mediterranean University
Mersin, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Merve Yurt, MS
Eastern Mediterranean University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Instructor
Study Record Dates
First Submitted
June 16, 2016
First Posted
June 22, 2016
Study Start
January 1, 2015
Primary Completion
November 1, 2015
Study Completion
January 1, 2016
Last Updated
June 22, 2016
Record last verified: 2016-06